OTC · Drug Manufacturers - Specialty & Generic

Cresco Labs Inc. (CRLBF) Stock

$0.68 +5.99% OTC: CRLBF Healthcare

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers.

Valuation

MetricValue
Price$0.68
Market Cap$240.87M
P/E Ratio-1.70
P/B Ratio0.73
P/S Ratio0.38
EPS (TTM)$-0.39
52-Week High$2.30
52-Week Low$0.54
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-35.26%
ROA-11.36%
ROCE6.05%
Gross Margin48.57%
Operating Margin10.41%
Net Margin-21.28%
Debt/Equity1.75
Current Ratio2.51

Annual Financials (USD)

Metric20212022202320242025
Revenue$822.0M$843.0M$771.0M$724.0M$667.0M
Operating Profit$-217.0M$-84.0M$-88.0M$107.0M$99.0M
Net Profit$-320.0M$-212.0M$-176.0M$-74.0M$-138.0M
EPS$-1.22$-0.71$-0.54$-0.22$-0.39
Op Margin-26.4%-10.0%-11.4%14.8%14.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.8B$1.6B$1.4B$1.4B$1.2B
Total Liabilities$983.0M$996.0M$930.0M$967.0M$943.0M
Cash$224.0M$119.0M$103.0M$138.0M$91.0M
Borrowings$625.0M$670.0M$683.0M$640.0M$583.0M

Latest News

Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026 Business Wire · Jul 13, 2026 GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out? Zacks · Jun 18, 2026 Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock? Zacks · Jun 11, 2026 Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank MT Newswires · Jun 8, 2026 Cresco Labs Registers Some Medical Cannabis Facilities With U.S. DEA MT Newswires · May 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$14.0M$19.0M$59.0M$132.0M$74.0M
Investing Cash Flow$-261.0M$-123.0M$-91.0M$-49.0M$-77.0M
Financing Cash Flow$74.0M$-84.0M$-44.0M$-28.0M$-8.0M
Net Cash Flow$85.0M$-105.0M$-13.0M$36.0M$-50.0M
Free Cash Flow$-83.0M$-67.0M$1.0M$109.0M$38.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA7.08
FCF Yield-0.09%
Quick Ratio1.41
Interest Coverage1.14
Return 1Y8.26%
Return 3Y-59.62%
Return 5Y—

Ownership

Insiders Held2.06%
Institutions Held3.48%
Institutions Float Held3.55%
Institutional HolderSharesReport Date
Ancora Advisors, LLC60,1692026-03-31
Albert D Mason Inc88,0352026-06-30
Curio Wealth, LLC 20,1612026-03-31
Hantz Financial Services, Inc. 9,0202026-03-31
Hurley Capital, Llc1,0142026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Cresco Labs Inc.

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.

Cresco Labs Inc. is headquartered in US.

Cresco Labs Inc. (CRLBF) stock trades at $0.68 with a market capitalization of $240.87M. The stock is valued at a price-to-earnings (P/E) ratio of -1.70, price-to-book of 0.73, price-to-sales of 0.38. Over the past 52 weeks the stock has ranged between $0.54 and $2.30, and currently trades 70.4% below its 52-week high.

On profitability, Cresco Labs Inc. generates a return on equity (ROE) of -35.26%, return on capital employed of 6.05%, an operating margin of 10.41%, a net profit margin of -21.28%.

Official website: www.crescolabs.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides